Login to Your Account


Reata’s IPO raises $52.5M to take AIM at regulatory proteins

By Michael Fitzhugh
Staff Writer

Thursday, May 26, 2016

Shares of Reata Pharmaceuticals Inc. (NASDAQ:RETA) climbed 18.8 percent to $13.07 from an IPO price of $11 on Thursday, in which the sale of 5.5 million shares raised net proceeds of $52.5 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription